(EL) EssilorLuxottica S. A. - Ratings and Ratios
Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0000121667
EL: Eyewear, Lenses, Sunglasses, Contact Lenses, Optical Equipment
EssilorLuxottica Société anonyme, a global leader in the design, production, and distribution of ophthalmic lenses, eyewear, and related technologies, operates across six continents, serving diverse markets in North America, the Middle East, Africa, Europe, Latin America, and the Asia-Pacific. The companys extensive portfolio includes corrective lenses, sunglasses, frames, and contact lenses under renowned brands such as Essilor, Varilux, Crizal, Ray-Ban, Oakley, and many others. It also offers specialized products like reading glasses and Blue Light filtering solutions under brands like Eyezen and Stellest.
Beyond consumer products, EssilorLuxottica provides advanced diagnostic and treatment solutions for eye care professionals. This includes multimodal imaging platforms like SPECTRALIS for comprehensive eye diagnostics, ANTERION for anterior segment imaging, and HEYEX 2 for integrated device management. The company also manufactures high-tech equipment for optical laboratories under the Satisloh brand, covering surfacing, polishing, coating, and finishing processes. Additionally, EssilorLuxottica supplies optometry instruments and tools for vision assessment, fitting, and medical record-keeping, catering to opticians, prescription laboratories, and healthcare institutions.
EssilorLuxottica distributes its products through a vast network of independent opticians, distributors, e-commerce platforms, and large retail chains. It also operates a significant brick-and-mortar retail presence and online sales channels, directly reaching consumers worldwide. Established in 1849 and headquartered in Paris, France, the company underwent a significant transformation in 2018 with the merger of Essilor International and Luxottica, creating a global eyecare and eyewear giant.
3-Month Forecast: Based on
Additional Sources for EL Stock
EL Stock Overview
Market Cap in USD | 132,949m |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
GiC Sub-Industry | Health Care Equipment |
IPO / Inception |
EL Stock Ratings
Growth Rating | 89.2 |
Fundamental | 61.1 |
Dividend Rating | 75.3 |
Rel. Strength | 27.8 |
Analysts | - |
Fair Price Momentum | 285.07 EUR |
Fair Price DCF | 322.60 EUR |
EL Dividends
Dividend Yield 12m | 3.36% |
Yield on Cost 5y | 7.84% |
Annual Growth 5y | 27.99% |
Payout Consistency | 98.0% |
EL Growth Ratios
Growth Correlation 3m | -57.9% |
Growth Correlation 12m | 91.5% |
Growth Correlation 5y | 92.2% |
CAGR 5y | 19.75% |
CAGR/Max DD 5y | 0.67 |
Sharpe Ratio 12m | 0.34 |
Alpha | 19.34 |
Beta | 0.664 |
Volatility | 37.23% |
Current Volume | 534.6k |
Average Volume 20d | 644.3k |
As of April 26, 2025, the stock is trading at EUR 253.30 with a total of 534,593 shares traded.
Over the past week, the price has changed by +0.04%, over one month by -8.62%, over three months by -1.67% and over the past year by +28.15%.
Yes, based on ValueRay Fundamental Analyses, EssilorLuxottica S. A. (PA:EL) is currently (April 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 61.08 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EL as of April 2025 is 285.07. This means that EL is currently undervalued and has a potential upside of +12.54% (Margin of Safety).
EssilorLuxottica S. A. has no consensus analysts rating.
According to ValueRays Forecast Model, EL EssilorLuxottica S. A. will be worth about 314 in April 2026. The stock is currently trading at 253.30. This means that the stock has a potential upside of +23.98%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 273.3 | 7.9% |
Analysts Target Price | - | - |
ValueRay Target Price | 314 | 24% |